Tango Therapeutics Inc.

NASDAQ: TNGX · Real-Time Price · USD
6.94
-0.28 (-3.88%)
At close: Aug 19, 2025, 3:59 PM
7.09
2.16%
After-hours: Aug 19, 2025, 06:32 PM EDT

Tango Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
42.07M 36.53M 24.86M 37.04M
Cost of Revenue
n/a 115.2M 4.03M 1.97M
Gross Profit
42.07M -78.67M 20.83M 35.08M
Operating Income
-145.59M -114.17M -111.07M -58.19M
Interest Income
7.89M 6.62M 1.46M 495K
Pretax Income
-130.09M -101.61M -108.12M -57.94M
Net Income
-130.3M -101.74M -108.18M -58.23M
Selling & General & Admin
43.75M 35.5M 30.02M 17.6M
Research & Development
143.92M 115.2M 105.91M 77.64M
Other Expenses
n/a n/a 2.95M 247K
Operating Expenses
187.66M 150.7M 135.93M 95.23M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
187.66M 150.7M 135.93M 95.23M
Income Tax Expense
208K 134K 54K 292K
Shares Outstanding (Basic)
109.23M 94.57M 87.82M 62.11M
Shares Outstanding (Diluted)
109.23M 94.57M 87.82M 62.11M
EPS (Basic)
-1.19 -1.08 -1.23 -0.94
EPS (Diluted)
-1.19 -1.08 -1.23 -0.94
EBITDA
-143.1M -111.76M -109.46M -57.29M
EBIT
-145.59M -114.17M -111.07M -58.19M
Depreciation & Amortization
2.5M 2.42M 4.03M 1.97M